SCHEMBL19978237

SCHEMBL19978237

CCCCS(=O)(=O)c1cnc(NC(=O)c2ccccc2)s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.54
TSHR P16473 1/20 0.54
KDR P35968 1/20 0.52
CCNE1 P24864 3/20 0.52
CDK2 P24941 3/20 0.52
CDK5 Q00535 2/20 0.52
SCD O00767 1/20 0.48
GRM4 Q14833 5/20 0.47
TP53 P04637 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
MAPT P10636 2/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
LCK P06239 1/20 0.43
PKM P14618 1/20 0.43
CCNE2 O96020 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4756407 0.85 STAT3 (0.51) ALDH1A1GRM4TP53SMN1; SMN2NPC1
SCHEMBL4757983 0.81 KDR (0.61) ALDH1A1TSHRKDRCCNE1CDK2
SCHEMBL4756409 0.81 ALDH1A1 (0.57) ALDH1A1TSHRGRM4TP53SMN1; SMN2
SCHEMBL722913 0.80 KDR (0.53) ALDH1A1TSHRKDRCCNE1CDK2
SCHEMBL4756880 0.79 GRM4 (0.45) ALDH1A1GRM4SMN1; SMN2NPC1RAB9A
SCHEMBL4757140 0.77 GRM4 (0.45) ALDH1A1GRM4SMN1; SMN2NPC1RAB9A
SCHEMBL12994121 0.77 MEN1 (0.38) ALDH1A1TSHRCCNE1CDK2CDK5
SCHEMBL11919154 0.74 ALDH1A1 (0.70) ALDH1A1TSHRKDRCCNE1CDK2
SCHEMBL4757159 0.72 MEN1 (0.57) ALDH1A1KDRCCNE1CDK2CDK5
SCHEMBL21450703 0.72 ALDH1A1 (0.52) ALDH1A1TSHRKDRCCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11850237-B2 Compounds and methods for treating influenza ROMARK LABORATORIES L.C. (US) 2023-12-26 US disclosed
US-11850237-B2 Compounds and methods for treating influenza ROMARK LABORATORIES L.C. (US) 2023-12-26 US disclosed
US-20210177809-A1 COMPOUNDS AND METHODS FOR TREATING INFLUENZA ROMARK LABORATORIES L.C. (US) 2021-06-17 US disclosed
US-10363243-B2 Compounds and methods for treating influenza ROMARK LABORATORIES L.C. (US) 2019-07-30 US disclosed
US-20180078533-A1 COMPOUNDS AND METHODS FOR TREATING INFLUENZA ROMARK LABORATORIES L.C. (US) 2018-03-22 US disclosed
US-20180078533-A1 COMPOUNDS AND METHODS FOR TREATING INFLUENZA ROMARK LABORATORIES L.C. (US) 2018-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180078533-A1 COMPOUNDS AND METHODS FOR TREATING INFLUENZA HIF1AN, HAVCR2, NEU1 ALDH1A1 77/4885TSHR 3190/4885KDR 4689/4885
US-20210177809-A1 COMPOUNDS AND METHODS FOR TREATING INFLUENZA HIF1AN, HAVCR2, NEU1 ALDH1A1 77/4885TSHR 3190/4885KDR 4689/4885
US-11850237-B2 Compounds and methods for treating influenza HIF1AN, HAVCR2, NEU1 ALDH1A1 77/4885TSHR 3190/4885KDR 4689/4885
US-10363243-B2 Compounds and methods for treating influenza HIF1AN, HAVCR2, NEU1 ALDH1A1 77/4885TSHR 3190/4885KDR 4689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.